Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Kor-Chem, Inc.
WARNING LETTER
•Kor-Chem, Inc.•May 5, 2023

Kor-Chem, Inc. – FDA Warning Letter, May 5, 2023

Record Details

The FDA inspected Kor-Chem, Inc.'s drug manufacturing facility from April 26 to May 5, 2023, identifying significant Current Good Manufacturing Practice (CGMP) violations, rendering their drug products adulterated under 21 U.S.C. 351(a)(2)(B). The firm indicated it had "discontinued" drug products. Violations included failure to establish adequate written procedures for equipment cleaning and maintenance (21 CFR 211.67(b)), particularly concerning shared equipment with corrosive industrial chemicals, posing cross-contamination risks. The firm also failed to test component samples for identity, purity, strength, and quality (21 CFR 211.84(d)(1)), and failed to validate supplier test analyses (21 CFR 211.84(d)(2)), specifically for high-risk components like glycerin (DEG/EG) and ethanol (methanol). Additionally, the firm failed to conduct appropriate microbiological testing for each drug product batch (21 CFR 211.165(b)). The Quality Control Unit failed to ensure CGMP compliance and meet specifications (21 CFR 211.22), with deficiencies in process validation, water system validation, analytical method validation, and stability programs. The FDA requires a comprehensive remediation plan, including risk assessments for previously manufactured drugs, a CAPA plan for operations oversight, detailed component testing procedures, and a full assessment of the Quality Unit. The firm is advised to engage a CGMP consultant and respond within 15 working days to avoid further regulatory action.

Company
Kor-Chem, Inc.
Inspection date
May 5, 2023
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations II
Person
  • Monica R. Maxwell (Program Division Director)
View Company Profile

ID · ce93b916-70b6-4ea8-86bd-b563e6c90f08

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.67(b)21 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.165(b)21 CFR 211.2221 CFR 211.100(a)21 CFR 211.160(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kor-Chem, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.